Get started
Author

Feyza Nur Arguc

Observed names: Arguc, Feyza Nur, Feyza Arguc
Observed institution: University of Missouri
ORCID: 0000-0003-1004-2653
Observed ORCID: 0000-0003-1004-2653
OpenAlex ID: A5085934112
Engineering pancreatic islets with a novel form of thrombomodulin protein to overcome early graft loss triggered by instant blood-mediated inflammatory reaction
2023 · Ali Turan, Lei Zhang, et al. · American Journal of Transplantation · 8
PDF
Progesterone signaling in oviductal epithelial cells modulates the immune response to support preimplantation embryonic development
2025 · Emily A. McGlade, Jiude Mao, et al. · Science Advances · 7
PDF
Oncolytic Adenovirus Armed with a Novel Agonist of the CD137 Immune Checkpoint Stimulator Suppresses Tumor Growth
2024 · Martin R. Ramos-Gonzalez, Mohammad Tarique, et al. · Vaccines · 3
PDF
Mechanisms of broad cancer immunoprevention efficacy of SA-4-1BBL
2026 · Feyza Nur Arguc · MOspace Institutional Repository (University of Missouri)
Abstract 965: A novel agonist of CD137, SA-4-1BBL, as a single agent halts spontaneous breast cancer progression
2026 · Yongyong Li, Sarita Rani, et al. · Cancer Research
Elucidating the Mechanisms of SA–4–1BBL-Mediated Cancer Immunoprevention Through Advanced Informatics Approaches
2026 · Mohit Verma, Feyza Nur Arguc, et al. · Biomolecules
PDF
Phagocytes play a critical role in the broad cancer immunoprevention efficacy of a novel agonist of CD137 pathway as a single agent 4286
2025 · Feyza Nur Arguc, Mohammad Tarique, et al. · The Journal of Immunology
PDF
Abstract LB390: Phagocytes play a critical role in the efficacy of a novel agonist of CD137 in preventing various tumor types
2025 · Feyza Nur Arguc, Mohammad Tarique, et al. · Cancer Research
Generation of a novel agonist of the human CD137 costimulatory pathway for cancer immunotherapy
2024 · Christa Jackson, Feyza Nur Arguc, et al. · The Journal of Immunology
PDF
Abstract 2465: A novel agonist of CD137 as a single agent shows cancer immunoprevention efficacy against various tumor types that is not dependent on the trained immunity
2024 · Feyza Nur Arguc, Mohammad Tarique, et al. · Cancer Research
Engineering islet surface with a novel form of thrombomodulin protein to mitigate instant blood-mediated inflammatory reaction following intraportal transplantation
2023 · Ali Turan, Lei Zhang, et al. · The Journal of Immunology
PDF
Abstract 3286: Development and characterization of an oncolytic adenovirus armed with the immune checkpoint stimulator SA-4-1BBL
2022 · Jorge G. Gómez-Gutiérrez, Martin Ramos-Gonzalez, et al. · Cancer Research
Works count: 14
Citation count: 18
H-index: 3
I10-index:
Year
Topic
Type